Bridgeway Capital Management, LLC Cyclerion Therapeutics, Inc. Transaction History

Bridgeway Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$0.96 - $1.78 $110,400 - $204,700	115,000 New	115,000 $128,000
Q2 2021 Aug 16, 2021	SELL	$2.18 - $4.29 $260,728 - $513,084	-119,600 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$2.69 - $5.12 $102,220 - $194,560	38,000 Added 46.57%	119,600 $334,000
Q4 2020 Feb 16, 2021	SELL	$2.25 - $7.12 $66,150 - $209,328	-29,400 Reduced 26.49%	81,600 $250,000
Q3 2020 Nov 16, 2020	BUY	$3.46 - $8.39 $173,000 - $419,500	50,000 Added 81.97%	111,000 $675,000
Q2 2020 Aug 14, 2020	BUY	$2.37 - $7.14 $144,570 - $435,540	61,000 New	61,000 $361,000

293K

Ticker CYCN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,479,800
Market Cap $139M
Description
Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.